Localization of metallothionein in breast carcinomas. An immunohistochemical study

Manuel Fresno1, Weiyu Wu2, Juana María Rodríguez3, Mehrdad Nadji2
1Department of Pathology, Hospital Covadonga, E-Oviedo, Spain
2Department of Pathology, University of Miami, Jackson Memorial Medical Center, Miami, USA
3Department of Gynecology, University of Oviedo, Hospital Covadonga, Oviedo, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Andrews PA, Murphy MP, Howell SB (1987) Metallothionein-mediated resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 19:149

Benerjee D, Onasaka S, Cherian MG (1982) Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm on rat liver and kidney. Toxicology 24:95–105

Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 9:359–377

Bremner I, Willians RB, Young BW (1977) Distribution of copper and zinc in the liver of the developing fetus. Br J Nutr 38:87–92

Cherian MG, Goyer RA (1978) Metallothioneins and their role in the metabolism and toxicity of metals. Life Sci 23:1–8

Eastman A, Richon VM (1985) Biochemical mechanisms of platinum antitumor drugs. Mc Brien DC, Slater TF (eds) Oxford IRL Press, pp 91

Kagi JRR, Nordberg M (1979) Metallothionein. Birkhause, Basel, pp. 48–116

Kagi JHR, Himmelhoch SR, Whanger PDD, Betheune JL, Vallee BL (1974) Equine hepatic and renal metalothioneins: purification, molecular weight, amino acid composition, and metal content. Biol Chem 249:3537–3542

Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

Kelleey SL, Basu A, Teicher BA, Halker MP, Hamer DH, Lazo JS (1988) Overexpression on MT confers resistance to anticancer drugs. Science 241:1813–1815

Kontozoglou TE, Banerjee D, Cherian G (1987) Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Arch [A] 415:545–549

Murphy D, Mcgown AT, Crowther D, Mander A, Fox BW (1991) Metallothionein levels in ovarian tumours before and after chemotherapy. Br J Cancer 63:711–714

Nartey N, Cherian MJ Banerjee D (1987) Immunohistochemical localization of metallothionein in human thyroid tumours. Am J Pathol 129:177–182

Nishimura H, Nishimura N, Tohyama C (1990) Localization of metallothionein in genital organs of the male rat. J Histochem Cytochem 38:927–933

Panemangalore M, Banerjee D, Onosaka S, Cherian MG (1983) Changes in intracellular accumulation and distribution of metal-lothionein in rat liver and kidney during postnatal development. Dev Biol 97:95–102

Peto P, Pike MC, Armitage P et al. (1977) Design and analyses of randomized clinical trials requiring prolonged observation of each patient. II. Analyses and examples. Br J Cancer, 35:1–39

Ryden L, Deutsh HF (1978) Preparation and properties of the major copper-binding component in human fetal liver. J Biol Chem 253:519–524

Schmid KW, Ellis IO, Gee JMV et al. (1993) Presence and possible significance of immunohistochemically demonstrable metal-lothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch [A] 422:153–159

Webb M, Cain K (1982) Functions of metallothionein. Biochem Pharmacol 31:137–142